1-10 of 10
Thierry Hercend
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

In vivo pre-clinical evaluation of the IGF-1R-specific antibody AVE1642 as single agent and in combination with Velcade    ®    /Bortezomib

Friedhelm Bladt, Patricia Vrignaud, Stephane Guerif, Noelle Boussac, Thomas Chittenden, Thierry Hercend, Marielle Chiron, Marie-Christine Bissery
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 4115.
Published: 01 May 2007
View article titled, In vivo pre-clinical evaluation of the IGF-1R-specific antibody AVE1642 as single agent and in combination with Velcade    <sup>®</sup>    /Bortezomib
Journal Articles

Early evaluation of the antimitotic and vascular targeting agent AVE8062A in melanoma tumor bearing mice using dynamic contrast enhanced-ultrasonography (DCE-US)

Sonia Lavisse, Pascale Lejeune, Marie-Christine Bissery, Nicolas Elie, Valerie Rouffiac, Aude Brule, Estelle Bribes, Brigitte Demers, Patricia Vrignaud, Thierry Hercend, Pierre Peronneau, Nathalie Lassau
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 233.
Published: 15 April 2006
View article titled, Early evaluation of the antimitotic and vascular targeting agent AVE8062A in melanoma tumor bearing mice using dynamic contrast enhanced-ultrasonography (DCE-US)
Journal Articles

Pre-clinical evaluation of the anti-tumor activity of the IGF1R - specific anitbody AVE1642

Friedhelm Bladt, Patricia Vrignaud, Marielle Chiron, Corinne Venot, Laurent Debussche, Rajeeva Singh, Thomas Chittenden, Thierry Hercend, Marie-Christine Bissery
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 289–290.
Published: 15 April 2006
View article titled, Pre-clinical evaluation of the anti-tumor activity of the IGF1R - specific anitbody AVE1642
Journal Articles

Preclinical evaluation of SAR3419 (huB4-DM4), an anti-CD19-maytansinoid immunoconjugate, for the treatment of B cell lymphomas

Robert J. Lutz, Claudia Zuany-Amorim, Patricia Vrignaud, Michele F. Mayo, Stephane Guerif, Hongsheng Xie, Véronique Blanc, Marie-Christine Bissery, Thierry Hercend
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 877–878.
Published: 15 April 2006
View article titled, Preclinical evaluation of SAR3419 (huB4-DM4), an anti-CD19-maytansinoid immunoconjugate, for the treatment of B cell lymphomas
Journal Articles

The anti insulin-like growth factor 1 receptor (IGF1-R) antibody AVE1642 exhibits anti-tumor activity against neuroblastoma cell lines and xenografts

Birgit Geoerger, Estelle Daudigeous, Laurent R J Debussche, Corinne Venot, Patricia Vrignaud, Thierry Hercend, Gilles Vassal
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 289.
Published: 15 April 2006
View article titled, The anti insulin-like growth factor 1 receptor (IGF1-R) antibody AVE1642 exhibits anti-tumor activity against neuroblastoma cell lines and xenografts
Journal Articles

In vivo evaluation of the antiangiogenic agent VEGF Trap, alone and in combination with 5-fluorouracil

Marielle Chiron, Patricia Vrignaud, Pascale Lejeune, Joyce Muller, Thierry Hercend, Marie-Christine Bissery
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 129.
Published: 01 May 2005
View article titled, In vivo evaluation of the antiangiogenic agent VEGF Trap, alone and in combination with 5-fluorouracil
Journal Articles

T-Cell Receptor Repertoire in Neuroblastoma Patients

Dominique Valteau, Véronique Scott, Guislaine Carcelain, Olivier Hartmann, Bernard Escudier, Thierry Hercend, Frédéric Triebel
Journal: Cancer Research
Cancer Res (1996) 56 (2): 362–369.
Published: 01 January 1996
View article titled, T-Cell Receptor Repertoire in Neuroblastoma Patients
Open the PDF for T-Cell Receptor Repertoire in Neuroblastoma Patients in another window
Journal Articles

Evidence for T-Cell Clonal Expansion in a Patient with Squamous Cell Carcinoma of the Head and Neck

Anne Caignard, Pierre Yves Dietrich, Valérie Morand, Annick Lim, Christophe Pannetier, Anne Marie Leridant, Thierry Hercend, Jos Even, Philippe Kourilsky, Frédéric Triebel
Journal: Cancer Research
Cancer Res (1994) 54 (5): 1292–1297.
Published: 01 March 1994
View article titled, Evidence for T-Cell Clonal Expansion in a Patient with Squamous Cell Carcinoma of the Head and Neck
Open the PDF for Evidence for T-Cell Clonal Expansion in a Patient with Squamous Cell Carcinoma of the Head and Neck in another window
Journal Articles

Evidence for in Situ Amplification of Cytotoxic T-Lymphocytes with Antitumor Activity in a Human Regressive Melanoma

Andreas Mackensen, Laurent Ferradini, Guislaine Carcelain, Frederic Triebel, Florence Faure, Sophie Viel, Thierry Hercend
Journal: Cancer Research
Cancer Res (1993) 53 (15): 3569–3573.
Published: 01 August 1993
View article titled, Evidence for <em>in Situ</em> Amplification of Cytotoxic T-Lymphocytes with Antitumor Activity in a Human Regressive Melanoma
Open the PDF for Evidence for <em>in Situ</em> Amplification of Cytotoxic T-Lymphocytes with Antitumor Activity in a Human Regressive Melanoma in another window
Journal Articles

Analysis of T-Cell Receptor α/β Variability in Lymphocytes Infiltrating a Melanoma Metastasis

Laurent Ferradini, Sergio Roman-Roman, José Azocar, Marie-Françoise Avril, Sophie Viel, Frédéric Triebel, Thierry Hercend
Journal: Cancer Research
Cancer Res (1992) 52 (17): 4649–4654.
Published: 01 September 1992
View article titled, Analysis of T-Cell Receptor α/β Variability in Lymphocytes Infiltrating a Melanoma Metastasis
Open the PDF for Analysis of T-Cell Receptor α/β Variability in Lymphocytes Infiltrating a Melanoma Metastasis in another window